T-cell enumeration from dried blood spots by quantifying rearranged T-cell receptor-β genes

Journal of Immunological Methods

Volumn 354, Issue 1-2, 2010, Pages 40-44

  Redd, Andrew D ^a   Ciccone, Emily J ^a   Nakigozi, Gertrude ^b   Keruly, Jeanne C ^c   Ndyanabo, Anthony ^b   Iga, Boaz ^b   Gray, Ronald H ^d   Serwadda, David ^e   Quinn, Thomas C ^a,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e MAKERERE UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Uganda)

Author keywords

Africa; Dried blood spots; HIV; T cell receptor

Indexed keywords

T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENE REARRANGEMENT; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; UGANDA; UNITED STATES;

ADULT; ANTI-RETROVIRAL AGENTS; BLOOD SPECIMEN COLLECTION; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DEVELOPING COUNTRIES; FEMALE; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; UGANDA; UNITED STATES;

EID: 77949916534     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.01.008     Document Type: Article

References (20)

1. Barnett D., Walker B., Landay A., Denny T.N. CD4 immunophenotyping in HIV infection. Nat. Rev. Microbiol. 2008, 6:S7.
2. Chain J.L., Joachims M.L., Hooker S.W., Laurent A.B., Knott-Craig C.K., Thompson L.F. Real-time PCR method for the quantitative analysis of human T-cell receptor gamma and beta gene rearrangements. J. Immunol. Methods 2005, 300:12.
3. Hallett T.B., Gregson S., Dube S., Garnett G.P. The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling. PLoS Med. 2008, 5:e53.
4. Hazenberg M.D., Hamann D., Schuitemaker H., Miedema F. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat. Immunol. 2000, 1:285.
5. Kagaayi J., Makumbi F., Nakigozi G., Wawer M.J., Gray R.H., Serwadda D., Reynolds S.J. WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda. Aids 2007, 21:1208.
6. Kitahata M.M., Gange S.J., Abraham A.G., Merriman B., Saag M.S., Justice A.C., Hogg R.S., Deeks S.G., Eron J.J., Brooks J.T., Rourke S.B., Gill M.J., Bosch R.J., Martin J.N., Klein M.B., Jacobson L.P., Rodriguez B., Sterling T.R., Kirk G.D., Napravnik S., Rachlis A.R., Calzavara L.M., Horberg M.A., Silverberg M.J., Gebo K.A., Goedert J.J., Benson C.A., Collier A.C., Van Rompaey S.E., Crane H.M., McKaig R.G., Lau B., Freeman A.M., Moore R.D. Effect of early versus deferred antiretroviral therapy for HIV on survival. N. Engl. J. Med. 2009, 360:1815.
7. Mathiot N.D., Krueger R., French M.A., Price P. Percentage of CD3+CD4-CD8-gammadeltaTCR- T cells is increased HIV disease. AIDS Res. Hum. Retroviruses 2001, 17:977.
8. McCune J.M. The dynamics of CD4+ T-cell depletion in HIV disease. Nature 2001, 410:974.
9. McDade T.W., Williams S., Snodgrass J.J. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 2007, 44:899.
10. Mwaba P., Cassol S., Pilon R., Chintu C., Janes M., Nunn A., Zumla A. Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients. Lancet 2003, 362:1459.
11. Palella F.J., Deloria-Knoll M., Chmiel J.S., Moorman A.C., Wood K.C., Greenberg A.E., Holmberg S.D. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann. Intern. Med. 2003, 138:620.
12. Parker S.P., Cubitt W.D. The use of the dried blood spot sample in epidemiological studies. J. Clin. Pathol. 1999, 52:633.
13. Redd A.D., Quinn T. Foreword: CD4 immunodiagnostics for HIV in the developing world. Nat. Rev. Microbiol. 2008, S1.
14. Siu G., Kronenberg M., Strauss E., Haars R., Mak T.W., Hood L. The structure, rearrangement and expression of D beta gene segments of the murine T-cell antigen receptor. Nature 1984, 311:344.
15. Spacek L.A., Gray R.H., Wawer M.J., Sewankambo N.K., Serwadda D., Wabwire-Mangen F., Kiwanuka N., Kigozi G., Nalugoda F., Quinn T.C. Clinical illness as a marker for initiation of HIV antiretroviral therapy in a rural setting, Rakai, Uganda. Int. J. STD AIDS 2006, 17:116.
16. Stevens W., Gelman R., Glencross D.K., Scott L.E., Crowe S.M., Spira T. Evaluating new CD4 enumeration technologies for resource-constrained countries. Nat. Rev. Microbiol. 2008, 6:s29.
17. UNAIDS AIDS Epidemic Update 2007.
18. UNFPA UNFPA: State of World Population 2007. Unleashing the Potential of Urban Growth 2007, UNFPA.
19. WHO. (2006 accessed Dec 10, 2009) Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. Recommendations for a public health approach. World Health Organization.
20. Ziemniak C., George-Agwu A., Moss W.J., Ray S.C., Persaud D. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts. J. Virol. Methods 2006, 136:238.